UK Drug Co. Settles For $19.6M Over False Safety Claims

Sat Jul 22 02:34:29 PDT 2023

By Katryna Perera

A New York federal judge has granted final approval to a $19.6 million
settlement between investors and U.K.-based consumer goods and health
conglomerate Reckitt Benckiser Group PLC, resolving claims that it
defrauded shareholders by not disclosing that regulators determined that
its drug used to treat narcotics dependency was more susceptible to
accidental child consumption.

 Order attached | Read full article » | Save to favorites »

https://www.law360.com/newyork/articles/1701714?nl_pk=00e0f28d-575b-4889-8d54-22105e2d7f39&utm_source=newsletter&utm_medium=email&utm_campaign=newyork&utm_content=2023-07-21&read_main=1&nlsidx=0&nlaidx=13
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: text/html
Size: 1208 bytes
Desc: not available
URL: <https://lists.cpunks.org/pipermail/cypherpunks/attachments/20230722/2a80a88c/attachment.txt>